114 related articles for article (PubMed ID: 2579880)
1. Lack of in vivo activation of the interferon system in HBsAg-positive chronic active hepatitis.
Poitrine A; Chousterman S; Chousterman M; Naveau S; Thang MN; Chaput JC
Hepatology; 1985; 5(2):171-4. PubMed ID: 2579880
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.
Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y
Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.
Andreone P; Cursaro C; Gramenzi A; Buzzi A; Miniero R; Sprovieri G; Gasbarrini G
J Hepatol; 1994 Dec; 21(6):984-8. PubMed ID: 7699263
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life.
Ikeda T; Lever AM; Thomas HC
Hepatology; 1986; 6(5):962-5. PubMed ID: 2428724
[TBL] [Abstract][Full Text] [Related]
5. Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy.
Hirai N; Shimizu M; Morioka T; Hinoue Y; Tanaka N; Kobayashi K; Hattori N; Hashimoto T
Liver; 1988 Jun; 8(3):138-45. PubMed ID: 3393063
[TBL] [Abstract][Full Text] [Related]
6. [Enzyme activity of interferon system in virus diseases].
Sokolova TM; Suetina IA; Nosik NN; Krylov VF
Biull Eksp Biol Med; 1991 May; 111(5):515-6. PubMed ID: 1715215
[TBL] [Abstract][Full Text] [Related]
7. 2',5' Oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during interferon treatment of chronic non-A, non-B hepatitis.
Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
Gastroenterol Jpn; 1991 Oct; 26(5):603-10. PubMed ID: 1752391
[TBL] [Abstract][Full Text] [Related]
8. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
[TBL] [Abstract][Full Text] [Related]
9. Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon.
Daito K; Suou T; Kawasaki H
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):303-16. PubMed ID: 8008980
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
[TBL] [Abstract][Full Text] [Related]
11. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients.
Ogawa Y
Gastroenterol Jpn; 1988 Jun; 23(3):279-86. PubMed ID: 2456963
[TBL] [Abstract][Full Text] [Related]
12. Activities of 2'-5'oligoadenylate synthetase in peripheral blood mononuclear cells of patients with viral hepatitis, and chronic type B hepatitis during interferon therapy.
Sugawara T; Matsushima T; Miyazaki T; Toyota J; Fujii N; Minagawa T
Jpn J Med; 1986 May; 25(2):144-8. PubMed ID: 3747259
[TBL] [Abstract][Full Text] [Related]
13. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
[TBL] [Abstract][Full Text] [Related]
14. Circulating acid-labile interferon in chronic versus acute, HBV-related liver disease. A marker of immune-mediated hepatocellular damage?
Biglino A; Cariti G; Gioannini P
Boll Ist Sieroter Milan; 1985; 64(3):201-6. PubMed ID: 2412572
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic significance of anti-HBc IgM (RIA) in healthy HBsAg carriers and in chronic hepatitis B.
Surrenti C; Ambu S; Patussi V; Milani S; Casini A; Zacchi P; Ceccatelli P; Cefaratti C; D'Agata A
J Med Virol; 1986 Mar; 18(3):229-34. PubMed ID: 3701301
[TBL] [Abstract][Full Text] [Related]
16. [Relation of hepatitis B virus markers in the serum and hepatic tissue in chronic carriers of HBsAg].
Ferraz ML; Lanzoni VP; Silva AE; Alberti VN; Pereira CA; Chiferi Júnior V; Guimarães RX
AMB Rev Assoc Med Bras; 1989; 35(2):63-6. PubMed ID: 2695985
[TBL] [Abstract][Full Text] [Related]
17. Relationship of the effects of interferon on chronic hepatitis B and the induction of 2',5'-oligoadenylate synthetase.
Nishiguchi S; Kuroki T; Otani S; Takeda T; Hirota S; Shimizu Y; Nakajima S; Saito S; Shiomi S; Kobayashi K
Hepatology; 1989 Jul; 10(1):29-33. PubMed ID: 2472340
[TBL] [Abstract][Full Text] [Related]
18. Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage.
Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
Gastroenterol Jpn; 1991 Apr; 26(2):162-9. PubMed ID: 1710193
[TBL] [Abstract][Full Text] [Related]
19. [Natural history of the state of asymptomatic carrier of HBsAg: 7-year follow-up].
Antoniozzi F; Meucci G; Vecchi M; Ronchi G; Collatina R; Del Ninno E; de Franchis R
Boll Ist Sieroter Milan; 1986; 65(5):347-53. PubMed ID: 3828089
[TBL] [Abstract][Full Text] [Related]
20. A comparison of interferon levels with leukocyte (2'-5') oligoadenylate synthetase activity as markers of viral encephalopathies.
Kennedy CR; Tilles JG
J Interferon Res; 1988 Oct; 8(5):609-15. PubMed ID: 2466911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
